undamentalytics Newsletter
Sign in

Omniab, Inc. balance sheet

At the end of fiscal 2025, Omniab, Inc. had total assets of $301m, total liabilities of $33.9m and shareholders' equity of $267m. It held $25.5m in cash against $0 of debt: net cash of $25.5m.

Balance sheet

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMSept 2026
Cash and equivalents03316282623
Receivables21304573
Inventory———011
Total current assets2312595686571
Goodwill848484848484
Total assets304421375326301291
Accounts payable334221
Deferred revenue (current)1187235
Total current liabilities212623151617
Total debt000000
Total liabilities708061383442
Shareholders' equity−8341315288267249
Non-controlling interests and other (assets − liabilities − equity)242—————
Net debt (negative = net cash)0−33−16−28−26−23
Shares outstanding——117m122m—146m

Balances at each fiscal year end (quarter end in the quarterly view). Total debt is short- plus long-term borrowings, including lease debt where the company reports it within debt. Where assets do not equal liabilities plus shareholders' equity, the difference (non-controlling interests, redeemable preferred shares) is shown on its own line.

Compare with peers

Head to head: OABI vs TKNOOABI vs RPIDMXCT vs OABIBNGO vs OABI

More: Life Sciences Tools & Services stocks compared, Health Care sector, rankings of US companies

Figures from Omniab, Inc.'s SEC filings (10-K and 10-Q), retrieved October 30, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Omniab, Inc.